JAHA:青少年时期的心血管状态与老年痴呆的发病率明显相关!

2018-12-29 MedSci MedSci原创

目前,关于研究青少年时期的心血管健康(CVH)与老年时期痴呆发生的相关性甚少。本研究将1967-1973年的CHA研究数据和1991-2010年的数据库相关联进行了分析,良好的心血管状态定义为未治疗状态下的收缩压/舒张压≤120/≤80mmHg,未治疗状态下的血清总胆固醇水平<5.18mmol/L,不抽烟,BMI<25kg/m2,且无糖尿病。在10119名基线水平的参与对象中,年龄范围

目前,关于研究青少年时期的血管健康(CVH)与老年时期痴呆发生的相关性甚少。

本研究将1967-1973年的CHA研究数据和1991-2010年的数据库相关联进行了分析,良好的血管状态定义为未治疗状态下的收缩压/舒张压≤120/≤80mmHg,未治疗状态下的血清总胆固醇水平<5.18mmol/L,不抽烟,BMI<25kg/m2,且无糖尿病。在10119名基线水平的参与对象中,年龄范围在23-47岁,女性占32.4%,黑人占9.2%,有7.3%的人有良好的心血管状态。经过随访,65岁后的痴呆发病率为13.9%,调整分析后发现,痴呆的发病率在心血管健康的人群中最低,且心血管危险因素越高,痴呆发病率越高。与拥有2个及以上的心血管危险因素人群相比,心血管健康、中等健康和有1个心血管危险因素人群的痴呆发病率要分别减少31%, 26%和20%。另外,这种相关性在男女性中均相似,在教育程度高和低的人群中也相似。

研究结果显示,青少年时期良好的心血管健康状态与老年低痴呆发病率呈相关性。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1823521, encodeId=5a901823521a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Jun 16 14:26:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356864, encodeId=203135686413, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 31 22:17:46 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268018, encodeId=e93e126801809, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Dec 31 01:26:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048521, encodeId=1ade104852127, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Dec 29 13:26:00 CST 2018, time=2018-12-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1823521, encodeId=5a901823521a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Jun 16 14:26:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356864, encodeId=203135686413, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 31 22:17:46 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268018, encodeId=e93e126801809, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Dec 31 01:26:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048521, encodeId=1ade104852127, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Dec 29 13:26:00 CST 2018, time=2018-12-29, status=1, ipAttribution=)]
    2018-12-31 医者仁心5538

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1823521, encodeId=5a901823521a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Jun 16 14:26:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356864, encodeId=203135686413, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 31 22:17:46 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268018, encodeId=e93e126801809, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Dec 31 01:26:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048521, encodeId=1ade104852127, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Dec 29 13:26:00 CST 2018, time=2018-12-29, status=1, ipAttribution=)]
    2018-12-31 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1823521, encodeId=5a901823521a1, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Jun 16 14:26:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356864, encodeId=203135686413, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 31 22:17:46 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268018, encodeId=e93e126801809, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Dec 31 01:26:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048521, encodeId=1ade104852127, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Dec 29 13:26:00 CST 2018, time=2018-12-29, status=1, ipAttribution=)]
    2018-12-29 junJUN

    老年人痴呆何药可用??

    0

相关资讯

JAHA:卒中预后的性别差异研究

女性卒中的预后往往差于男性,这被认为可能是卒中严重程度不同导致的。本研究的目的旨在通过美国国立卫生研究院中风量表来评估造成急性卒中预后性别差异的因素。本研究纳入了INSTRUCT临床研究中的6343名卒中患者,并对患者的人口社会学资料、卒中相关临床因素、并发症和卒中前功能进行了评估。最终,在5570名缺血性卒中患者中有5326名(96%)患者获得了美国国立卫生研究院中风量表评分,在855名颅内出血

Medscape盘点|2018年度心血管领域的Top研究

2018年心血管领域多项重磅研究、重要指南相继发布,疾病治疗理念与技术更新的步伐也在加速,这些重要的进展也在促使我们的临床实践发生着悄然改变。

Heart:心脏杂音诊所——一种检查心脏瓣膜疾病的新模式

本研究的目的旨在评估听诊或现场及时检查能否减少社区无症状心脏杂音患者的经胸超声心动图检查率。有心脏杂音的对象由全科医生转诊至心脏杂音诊所,由心脏病专家或科学家进行了听诊和及时体检。由心脏病专家接诊的患者有75名,平均年龄54岁(女性占56名),由科学家接诊的患者有100名,平均年龄为60岁(女性占76名),在所有的175名患者中,心超检查出异常的有52名(30%),及时检查出异常的有52名(30%

JACC:超薄冠脉药物洗脱支架植入远期预后更佳

冠脉药物洗脱支架的发展以及引进了新的金属合金材料,改变了支架的金属构造和生物可吸收聚合物,但这些改进带来的安全性和有效性在之前的研究中结果是不一致的。本研究的目的旨在比较和评估超薄支柱(60μm)生物可吸收聚合物西罗莫司洗脱支架(BP SES)和薄支柱(81μm)耐用聚合物伊维莫司洗脱支架(DP EES)的远期安全性和有效性。本次临床研究为BIOFLOW V临床试验,旨在比较BP SES和DP E

JAHA:跑步训练对外周动脉疾病患者预后的影响

目前在外周动脉疾病的患者中,时长6个月的有监督的跑步运动是否对患者的6分钟行走试验有帮助尚不清楚。本研究共纳入了156名外周动脉疾病患者,并随机分成三组:有监督的跑步运动组,有监督的阻力训练组和对照组。主要终点事件是6个月后6分钟行走距离的变化,次要终点事件是12个月后6分钟行走距离的变化。最终共有134名(86%)患者完成了12个月的随访,在前6个月,与对照组相比,跑步运动组患者的6分钟行走距离

JAHA:调节性T细胞可以保护高血压引起的脑血管损伤

免疫细胞是高血压血管炎症反应的关键调控因子,在高血压啮齿动物中,有调控作用的T淋巴细胞(调节性T细胞、CD4+CD25+)可以保护血管的损伤、心脏的损伤和肠系膜动脉的内皮功能。然而,调节性T细胞能否保护高血压引起的脑血管损伤尚不清楚。本研究对C57BL/6小鼠进行了血管紧张素II(AngII; 1000ng/kg 每分钟)灌注处理14天,并通过2次静脉内注射灌输了3×105个CD4+CD25+T细